Regenxbio Inc (RGNX)
9.18
-0.45
(-4.67%)
USD |
NASDAQ |
Nov 21, 16:00
9.26
+0.08
(+0.87%)
Pre-Market: 08:26
Regenxbio Profit Margin (Quarterly): -246.3% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -246.3% |
| June 30, 2024 | -237.7% |
| March 31, 2024 | -405.4% |
| December 31, 2023 | -283.1% |
| September 30, 2023 | -214.0% |
| June 30, 2023 | -360.7% |
| March 31, 2023 | -348.4% |
| December 31, 2022 | -191.2% |
| September 30, 2022 | -284.7% |
| June 30, 2022 | -208.8% |
| March 31, 2022 | -345.3% |
| December 31, 2021 | 73.75% |
| September 30, 2021 | -189.8% |
| June 30, 2021 | -261.6% |
| March 31, 2021 | -265.5% |
| December 31, 2020 | -215.6% |
| September 30, 2020 | 8.89% |
| June 30, 2020 | -203.8% |
| March 31, 2020 | -226.9% |
| December 31, 2019 | -224.9% |
| September 30, 2019 | -235.3% |
| Date | Value |
|---|---|
| June 30, 2019 | -18.49% |
| March 31, 2019 | -3.65K% |
| December 31, 2018 | 10.56% |
| September 30, 2018 | -361.9% |
| June 30, 2018 | 26.46% |
| March 31, 2018 | 78.74% |
| December 31, 2017 | -784.2% |
| September 30, 2017 | -1.55K% |
| June 30, 2017 | -220.6% |
| March 31, 2017 | -4.83K% |
| December 31, 2016 | -1.16K% |
| September 30, 2016 | -14.52K% |
| June 30, 2016 | -607.9% |
| March 31, 2016 | -2.74K% |
| December 31, 2015 | -116.4% |
| September 30, 2015 | -643.2% |
| June 30, 2015 | -461.5% |
| March 31, 2015 | -622.8% |
| December 31, 2014 | -203.5% |
| September 30, 2014 | -371.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-405.4%
Minimum
Mar 2024
73.75%
Maximum
Dec 2021
-231.6%
Average
-232.3%
Median
Profit Margin (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 34.10% |
| EyePoint Pharmaceuticals Inc | -279.0% |
| Cassava Sciences Inc | -- |
| Vertex Pharmaceuticals Inc | 37.71% |
| Sarepta Therapeutics Inc | 7.19% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -69.61% |
| Return on Assets | -40.81% |
| Return on Invested Capital | -69.61% |
| Gross Profit Margin (Quarterly) | 48.81% |
| Operating Margin (Quarterly) | -256.6% |
| Return on Net Operating Assets | -106.8% |